CDXS Codexis, Inc.
$1.26▼ -1.56%
Healthcare
Other
After hours
$1.27▲ +0.79%
Oct 28, 4:47 PM ET
Volume 1.65M
Avg Volume (10D) 821.8K
Key Metrics & Fundamentals
Market Cap
$137.98M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.96 - 2.98
% vs 50 MA
-11.03%
% vs 200 MA
-30.88%
RSI-14
42.6
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.81
Free Cash Flow
-$10.54M
Gross Rev
$14.92M
Gross Profit
$11.40M
EBITDA
-$8.54M
COGS
$3.51M
Operating Exp
$22.63M
Operating Income
-$11.23M
EBIT
-$11.23M
Pretax Income
-$12.00M
Net Income
-$12.01M
EPS (Diluted)
-0.13
Price & Volume History
Loading chart…
Recent News
Temporary Delays in siRNA Manufacturing Mask Codexis’ (CDXS) High-Option Value
Insider Monkey · Oct 22, 2026 9:12 AM ET
Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA
GlobeNewswire · Sep 28, 2026 6:00 AM ET
What Needs To Be True To Buy Twist Bioscience Stock Now?
Trefis · Sep 25, 2026 6:29 PM ET
Codexis to Participate in Cantor Global Healthcare Conference 2026
GlobeNewswire · Aug 27, 2026 9:00 AM ET
Codexis (CDXS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 18, 2026 7:27 PM ET
Codexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · Aug 14, 2026 12:00 PM ET
Codexis Inc (CDXS) (Q2 2026) Earnings Call Highlights: Biocatalysis Growth and ECO Synthesis ...
GuruFocus.com · Aug 12, 2026 1:02 AM ET
Codexis, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 11, 2026 9:44 PM ET
Codexis Q2 Earnings Call Highlights
MarketBeat · Aug 11, 2026 6:04 PM ET
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 11, 2026 5:45 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CDXS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.